ArticleWorld journal of microbiology & biotechnology2025
Control of aflatoxin in broiler feeds through dietary supplementation with Pichia kudriavzevii B-5P: effects on performance, serum biochemistry and histopathological change - a promosing strategy.
Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Aflatoxin is a mycotoxin that contaminates many grain feed ingredients, especially corn. Pichia kudriavzevii B-5P is a yeast strain with potential application in the mitigation of Aspergillus flavus and its associated aflatoxins. This research aims to optimize the dose of Pichia kudriavzevii B-5P as a toxin binder in corn containing aflatoxin in broiler chicken rations along with in vivo evaluation of its protection efficiency on performance, carcass characteristics, serum biochemistry and histopatholical alteration in the liver, kidneys and intestines. This research used a Completely Randomized Design (CRD), 4 treatments and 5 replications. Treatment consisted of T1: control (no aflatoxin); T2: 0,1% P. kudriavzevii B-5P; T3: 0,2% P. kudriavzevii B-5P; T4: 0,3% P. kudriavzevii B-5P. Performance (consumption, weight gain, feed conversion, live weight, and carcass), abdominal fat, percentage of organ weight (liver, kidney, and small intestine), and total protein, albumin, and globulin were not significantly different (p > 0.05) between the control group (without aflatoxin) and the group of chickens fed aflatoxin (191.95 ppb) + Pichia kudriavzevii B-5P. Histopathologically, the liver, kidneys, and small intestine showed mild damage that tended to improve with the administration of P. kudriavzevii B-5P, thereby not affecting organ function. The results of the study concluded that giving Pichia kudriavzevii B-5P as much as 0.1% in feed can overcome aflatoxin contamination with a level of 191.95 ppb in broiler chickens.
Indexed as
Identifiers
40498377What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.